Pharma Industrial India - Professional magazine for pharma industry suppliers and lab technology

NEWS ABOUT >

Biotechnology

Clean Rooms

Clinical Trials

Consultants

Digitalization

Drug Discovery & Development

Engineering

Global Pharma

Industrial talks

Ingredients

Lab Equipment

Logistics & Distribution

Manufacturing

Market

Outsourcing

Packaging

Quality / GMP

Regulation

Safety

Last edition

All magazines
Subscribe to our magazine

News about "sonesitatug vedotin"

AstraZeneca and Summit Therapeutics Partner on ADC Cancer Strategy

AstraZeneca has announced strategic equity investment and clinical collaboration with Summit Therapeutics to advance leading ADC combination strategy in cancer.

Sonesitatug Vedotin | 01/10/2026 | By News Bureau

AstraZeneca's Sone-Ve Phase 3 Trial Delivers Survival Breakthrough in Advanced CLDN18.2 Positive Gastric Cancer

AstraZeneca's investigational antibody-drug conjugate Sone-Ve demonstrated a significant overall survival benefit in the Phase 3 CLARITY-Gastric01 trial, marking a milestone in the development of targeted therapies for CLDN18.2-positive advanced gastric cancer.

Sonesitatug Vedotin | 28/07/2026 | By News Bureau

We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.

More information: Privacy Policy

pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members